Fundz

Aclaris Therapeutics, Inc. reported raising $20 Million in an initial SEC Form D filing, from an offering of $20 Million

PUBLIC · ACRSJun 14, 2016

Amount Raised

$20 Million

$20 Million sold, per SEC Form D (first sale Jun 14, 2016)

Round Type

Venture

WayneHealthcare

Who to call at Aclaris Therapeutics, and when

A new round usually means Aclaris Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Aclaris Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aclaris Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aclaris Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aclaris Therapeutics

Location

701 Lee Road

Wayne, Pennsylvania, United States

About

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aclaris Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts45 people are listed at Aclaris Therapeutics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Aclaris Therapeutics's next move

See what Strategic adds

Aclaris Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.